Dr. Nathan Russo Marchand , MD
General Practice • Beaumont, TX
3030 North St, Suite 430
Beaumont, TX 777021433
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Nathan Marchand is listed in NPPES under General Practice.
-
NPI assigned on September 7, 2006; this date does not establish years in practice.
-
Published CMS data list 2,294 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99232 — Subsequent hospital care with moderate levelof medical decision making: 501 service units.
- 99214 — Established patient outpatient office visit: 391 service units.
- 99231 — Subsequent hospital care with straightforward or low level of medical decision making, per day: 297 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 20 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 6,439 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Atorvastatin Calcium — 504 prescription fills, including refills.
- Rosuvastatin Calcium — 228 prescription fills, including refills.
- Pantoprazole Sodium — 223 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 123 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 80% of clinicians listed under General Practice in Texas (2024, 172 clinicians with data). Median for this group: 341. Middle half: 100 to 1,551.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 2,171 in 2020 to 2,294 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
3030 North St
Suite 430
Beaumont, TX 777021433
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Beaumont Dermatology And Family Practice, Llp. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Tulane University School Of Medicine
2001
What Public CMS Data Show
General Practice: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
475 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $154,084 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $113,058 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
13,418 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$657,545 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $307.16 across 16 records.
By nature of payment
- Food and Beverage: $307.16 across 16 records.
Reporting-company totals (3 largest of 6)
- Pfizer Inc.: $104.74 across 5 records.
- Novo Nordisk Inc: $57.70 across 3 records.
- GlaxoSmithKline, LLC.: $47.69 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
25 years (graduated 2001)
CMS Doctors and Clinicians data list 2001 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Marchand has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Marchand as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Beaumont and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 80% of clinicians listed under General Practice in Texas (2024, 172 clinicians with data). Median for this group: 341. Middle half: 100 to 1,551.
Too few clinicians listed under General Practice in Beaumont have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 80% of clinicians listed under General Practice in Texas (2024, 172 clinicians with data). Median for this group: $28,596. Middle half: $8,918 to $83,485.
Too few clinicians listed under General Practice in Beaumont have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 80% of clinicians listed under General Practice in Texas (2024, 172 clinicians with data). Median for this group: $19,146. Middle half: $6,451 to $65,134.
Too few clinicians listed under General Practice in Beaumont have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 85% of clinicians listed under General Practice in Texas (2024, 221 clinicians with data). Median for this group: 452. Middle half: 78 to 2,858.
Too few clinicians listed under General Practice in Beaumont have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under General Practice in Texas (2024, 221 clinicians with data). Median for this group: $17,804. Middle half: $993 to $222,529.
Too few clinicians listed under General Practice in Beaumont have Medicare Part D data for 2024 to compare.
5 active clinicians are listed under General Practice with a practice address in Beaumont, TX (1,066 in Texas).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services stayed about the same: 2,171 in 2020 and 2,294 in 2024.
- 2020: 2,171
- 2021: 2,063
- 2022: 2,287
- 2023: 2,440
- 2024: 2,294
-
Medicare-allowed amount
Medicare-allowed amount increased 10% from $139,515 in 2020 to $154,084 in 2024.
- 2020: $139,515
- 2021: $149,314
- 2022: $162,948
- 2023: $170,753
- 2024: $154,084
-
Paid by Medicare
Paid by Medicare increased 13% from $100,382 in 2020 to $113,058 in 2024.
- 2020: $100,382
- 2021: $111,504
- 2022: $120,829
- 2023: $128,706
- 2024: $113,058
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 26% from 5,111 in 2020 to 6,439 in 2024.
- 2020: 5,111
- 2021: 4,949
- 2022: 4,980
- 2023: 5,151
- 2024: 6,439
-
30-day fills
30-day fills increased 22% from 11,033 in 2020 to 13,418 in 2024.
- 2020: 11,033
- 2021: 10,892
- 2022: 10,754
- 2023: 11,078
- 2024: 13,418
-
Part D drug cost
Part D drug cost increased 98% from $332,581 in 2020 to $657,545 in 2024.
- 2020: $332,581
- 2021: $354,034
- 2022: $393,652
- 2023: $462,479
- 2024: $657,545
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $88.80 in 2021 to $307.16 in 2025.
- 2021: $88.80
- 2022: $96.88
- 2023: $139.58
- 2024: $455.20
- 2025: $307.16
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 16 records totaling $307.16.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
AREXVY | General | $26.66 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
ELIQUIS | General | $23.69 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
ELIQUIS | General | $22.24 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
ELIQUIS | General | $21.68 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $21.03 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
ELIQUIS | General | $20.66 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $19.88 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $19.60 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Rybelsus | General | $19.05 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $18.77 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $17.32 |
| Kowa Pharmaceuticals America, Inc. |
Food and Beverage
In-kind items and services
|
ZORYVE | General | $16.49 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
NURTEC ODT | General | $16.47 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
REPATHA | General | $15.56 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $14.03 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $14.03 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
501 | 191 | $100.00 | $68.91 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
391 | 158 | $175.00 | $110.74 |
|
99231
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
|
297 | 138 | $65.00 | $43.38 |
|
99222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
|
225 | 204 | $165.00 | $113.71 |
|
J1100
Injection, dexamethasone sodium phosphate, 1 mg
|
184 | 21 | $1.00 | $0.11 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
149 | 93 | $125.00 | $79.17 |
|
99238
Hospital discharge day management, 30 minutes or less
|
149 | 139 | $105.00 | $70.52 |
|
J3301
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
|
74 | 16 | $8.00 | $0.89 |
|
99239
Hospital discharge day management, more than 30 minutes
|
61 | 58 | $160.00 | $99.55 |
|
36415
Insertion of needle into vein for collection of blood sample
|
38 | 29 | $10.00 | $8.65 |
|
87804
Detection test by immunoassay with direct visual observation for influenza virus
|
35 | 14 | $30.00 | $16.22 |
|
G0008
Administration of influenza virus vaccine
|
34 | 34 | $35.00 | $27.76 |
|
96372
Injection of drug or substance under skin or into muscle
|
33 | 27 | $35.00 | $12.00 |
|
90653
Influenza vaccine, inactivated
|
31 | 31 | $90.81 | $76.54 |
|
81003
Automated urinalysis test
|
19 | 17 | $10.00 | $2.08 |
|
93000
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report
|
18 | 17 | $50.00 | $11.85 |
|
87426
Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus
|
16 | 13 | $60.00 | $34.62 |
|
20610
Aspiration and/or injection of fluid from large joint
|
14 | 13 | $150.00 | $53.80 |
|
99233
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
|
13 | 11 | $130.00 | $103.18 |
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
12 | 12 | $250.00 | $151.59 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 504 | 39,309 | $4,575.35 | 160 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 228 | 19,607 | $2,785.82 | 67 |
| Pantoprazole Sodium | Pantoprazole Sodium | 223 | 14,426 | $2,567.83 | 81 |
| Hydrochlorothiazide | Hydrochlorothiazide | 220 | 16,791 | $964.45 | 71 |
| Gabapentin | Gabapentin | 173 | 8,531 | $2,105.50 | 55 |
| Losartan Potassium | Losartan Potassium | 169 | 13,479 | $1,857.61 | 62 |
| Levothyroxine Sodium | Levothyroxine Sodium | 158 | 11,641 | $2,708.39 | 42 |
| Metoprolol Succinate | Metoprolol Succinate | 152 | 11,730 | $2,259.68 | 55 |
| Metformin Hcl | Metformin Hcl | 142 | 11,940 | $820.71 | 49 |
| Lisinopril | Lisinopril | 139 | 10,377 | $915.99 | 44 |
| Tamsulosin Hcl | Tamsulosin Hcl | 134 | 10,090 | $1,758.84 | 41 |
| Amlodipine Besylate | Amlodipine Besylate | 127 | 8,845 | $610.17 | 41 |
| Ozempic | Semaglutide | 126 | 4,798 | $144,611.49 | 27 |
| Potassium Chloride | Potassium Chloride | 107 | 5,668 | $1,291.96 | 49 |
| Carvedilol | Carvedilol | 105 | 6,375 | $593.01 | 37 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 101 | 7,950 | $1,831.77 | 31 |
| Ezetimibe | Ezetimibe | 97 | 8,610 | $1,765.89 | 34 |
| Metoprolol Tartrate | Metoprolol Tartrate | 91 | 6,892 | $613.78 | 34 |
| Famotidine | Famotidine | 88 | 7,073 | $1,037.26 | 38 |
| Fluticasone Propionate | Fluticasone Propionate | 87 | 4,410 | $1,148.11 | 37 |
| Escitalopram Oxalate | Escitalopram Oxalate | 85 | 5,742 | $860.12 | 30 |
| Duloxetine Hcl | Duloxetine Hcl | 81 | 3,444 | $1,153.81 | 21 |
| Jardiance | Empagliflozin | 78 | 3,970 | $78,557.01 | 19 |
| Omeprazole | Omeprazole | 77 | 5,657 | $798.47 | 21 |
| Prednisone | Prednisone | 76 | 1,072 | $247.35 | 56 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-01-08NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
NUCC Taxonomy Code: 207Q00000X
Family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - FAMILY PRACTICE
I20080306000134
TX
3678478633
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Beaumont Dermatology And Family Practice, Llp
3030 N St, Beaumont, TX 777021434
Phone: 4098992500
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Physician Assistant
Physician Assistant (Certified)
General Practice
Doctor of Medicine (M.D.)
Dermatology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Family Medicine (license number reported to NPPES: TX M7400)
General Practice (license number reported to NPPES: TX M7400)
NPI status registered as active in NPPES database
Registered at 3030 NORTH ST, SUITE 430, BEAUMONT, TX 777021433 (Tel: 4098992500)
Registered at 3030 NORTH ST, SUITE 430, BEAUMONT, TX 777021433 (Tel: 4098992500)
Recorded as NATHAN MARCHAND, MD
Family Medicine (license number reported to NPPES: TX M7400)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other General Practices in Beaumont
Healthcare providers in BeaumontMailing Address
3030 North St, Suite 430
Beaumont, TX 777021433
Phone: 4098992500